期刊
HAUTARZT
卷 71, 期 7, 页码 553-556出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00105-020-04599-y
关键词
PD-L1 inhibition; Neoplasm metastasis; Immune function; Therapeutic response; Synergistic effect
类别
We report the case of an 85-year-old chronic lymphocytic leukemia patient with a local metastatic MCVPyV-negative Merkel cell carcinoma at initial diagnosis. Therapy comprised surgical excision and radiotherapy but without lymphadenectomy. Six months after the primary diagnosis, liver metastases were detected. They responded to the PD-L1 inhibitor avelumab for more than 15 months. Thus, we postulate a synergistic effect of combined therapy with chlorambucil and avelumab through a mutual improvement of immune function, from which both diseases benefit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据